Hims & Hers expects Q4 revenue of $875M-$895M and prepares broader GLP-1 range and international marketing
FROM THE WIRE · SEEKINGALPHA.COM
Earnings Call Insights: Hims & Hers Health (HIMS) Q3 2026 MANAGEMENT VIEW * "Revenue growth accelerated to nearly 50% this quarter. Nearly 3 million people across 4 continents rely on us to access care." (Co-Founder, Chairman & CEO Andrew Dudum) * "The weight loss business has…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: neutralQ4 revenue guidance and reduced marketing spend shape expectations for the stock's growth.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Revenue growth accelerated to nearly 50% this quarter, with nearly 3 million people across 4 continents using the service.
- 02The company pulled back on weight loss marketing spend to prepare a broader metabolic assortment with Lilly and Novo.
- 03Hims & Hers expects Q4 revenue of $875M-$895M and plans brand consolidation in the U.K., Germany and Australia.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets